The AMP Annual Meeting & Expo hosted by the Association for Molecular Pathology, was the premier gathering for molecular professionals. Their 25th anniversary was a celebration of their close-knit community and of the technical advancements and legislative achievements shared over the years. It was also an opportunity to look to the future, and to explore how we can continue to provide the highest quality of care for our patients in an evolving medical landscape.
XIFIN participated as an exhibitor and panelist.
New Players in Reimbursement: Laboratory Benefit Managers
Heather Agostinelli, AVP Strategic Revenue Operations, XIFIN, Inc.
Friday, November 8, 2019
1:30 PM - 2:45 PM ET
Geoffrey Baird, MD, PhD, University of Washington
Trisha Brown, MS, LCGC, Illumina, Inc.
The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,500+ members include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.